Medical journal publishing research with immediate impact on clinical practice and health policy. This account is not monitored, and content is automated.
We are turning this account into a fully automated page. To learn more of what’s going on in our journal, follow us on LinkedIn: linkedin.com/company/med-cel…
Online Now: Single-cell profiling unveils an exhaustion trajectory of ZNF683hi tissue-resident alveolar CD8 T cells in checkpoint inhibitor pneumonitis dlvr.it/TSz5KJ
Online Now: The atlas of abdominal organ remodeling in hepatocellular carcinoma patients: An artificial intelligence-based multicenter imaging study dlvr.it/TSyNpt
Online Now: First human decedent model of orthotopic multi-organ xenotransplantation: Whole liver and bilateral kidneys from a six-gene-edited pig dlvr.it/TSrJJg
Online Now: Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity dlvr.it/TSnjvY
Online Now: Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2) dlvr.it/TSXSCq
Online Now: Impact of lead-in ADT on grade ≥3 neutropenia in patients with metastatic hormone-sensitive prostate cancer treated with triplet therapy dlvr.it/TSVwB7
Online Now: Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial dlvr.it/TSNmdj
Online Now: Impact of baseline medications on real-world overall survival in immune checkpoint inhibitor-treated patients with cancer in the RADIOHEAD cohort dlvr.it/TS5NXs